Valuation : Amarin Corporation plc

Market Cap 291M 251M 238M 216M 404M 27.85B 407M 2.82B 1.09B 14.15B 1.09B 1.07B 44.76B P/E 2026 *
-197x
P/E 2027 * -230x
Enterprise Value 129M 111M 105M 95.59M 179M 12.35B 180M 1.25B 481M 6.27B 485M 475M 19.84B EV / Sales 2026 *
0.73x
EV / Sales 2027 * 0.66x
Free-Float
86.93%
Yield 2026 *
-
Yield 2027 * -
1 day-1.71%
1 week+1.25%
Current month-0.58%
1 month-1.85%
3 months-9.45%
6 months-15.70%
Current year-1.11%
1 week 13.19
Extreme 13.19
14.4
1 month 13.19
Extreme 13.19
15.24
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
27.4
5 years 7.08
Extreme 7.08
110.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 43 28/02/2023
Director/Board Member 67 28/02/2023
Date Insider Type Main position Quantity % Market Cap. Importance
01/08/26 Exercice

Chief Financial Officer

781 0.0002%
01/07/26 Exercice

Chief Operating Officer

9,302 0.0022%
01/07/26 Exercice

Chief Technology Officer

9,263 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-1.71%+1.25%-8.06%-32.35% 291M
-2.11%-1.68%+44.52%+95.15% 66.93B
-0.23%-4.45%+32.50%+75.75% 61.97B
+1.67%+2.47%-11.32%+380.54% 28.27B
-1.05%-4.43%+30.56%+10.07% 24.59B
+0.34%-6.78%-0.01%-16.35% 24.3B
+0.43%-3.37%+14.85%-19.29% 19.41B
-3.03%-2.29%+185.12%+334.07% 16.77B
-1.94%-4.94%-5.29%+495.65% 14.18B
-2.28%-4.90%+43.35%+154.05% 13.91B
Average -0.99%-2.99%+32.62%+147.73% 27.06B
Weighted average by Cap. -0.84%-3.06%+34.53%+133.25%

Financials

2026 *2027 *
Net sales 177M 153M 145M 131M 246M 16.95B 248M 1.72B 661M 8.62B 666M 652M 27.25B 177M 152M 144M 131M 245M 16.9B 247M 1.71B 658M 8.59B 664M 649M 27.15B
Net income -26.62M -22.96M -21.73M -19.7M -36.92M -2.54B -37.14M -258M -99.13M -1.29B -99.99M -97.78M -4.09B -18.32M -15.8M -14.95M -13.55M -25.41M -1.75B -25.56M -177M -68.21M -889M -68.8M -67.28M -2.81B
Net Debt -162M -140M -132M -120M -225M -15.5B -226M -1.57B -604M -7.88B -609M -596M -24.92B -175M -151M -143M -129M -243M -16.71B -244M -1.69B -651M -8.49B -657M -642M -26.85B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
11/09/26 $13.80 -1.71% 49,369
10/09/26 $14.04 -2.43% 51,753
09/09/26 $14.39 +0.98% 33,687
08/09/26 $14.25 +4.55% 99,807
04/09/26 $13.63 -0.58% 80,559
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
13.80USD
Average target price
12.50USD
Spread / Average Target
-9.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!